Evigrade
Moderate

Ciclosporin × Digoxin

Immunosuppressants. Calcineurin inhibitors×Cardiac glycosides (digitalis)

Mechanism

Ciclosporin inhibits P-glycoprotein in gut and renal tubules, reducing digoxin clearance. Digoxin AUC rises by 50–100%; toxicity risk is substantial.

Symptoms

Nausea, vomiting, loss of appetite, confusion, yellow-green halos around lights, arrhythmia (bigeminy, AV block). Symptoms appear earlier in older patients and chronic kidney disease.

Management

On ciclosporin start, reduce digoxin dose by 25–50% and check levels at 5–7 days. Target: 0.5–0.8 ng/mL. In parallel, monitor potassium and creatinine (ciclosporin is nephrotoxic and raises hyperkalaemia risk).

Sources

All interactions